Celgene (CELG) Adds $3B to Buyback Plan

June 12, 2013 8:01 AM EDT Send to a Friend
Celgene Corp (NASDAQ: CELG) announced today that its Board of Directors authorized the repurchase of up to an additional $3.0 billion of the Company’s common stock. Purchases may be made in the open market or in privately negotiated transactions from time to time, as determined by management and in accordance with applicable requirements of the Securities and Exchange Commission.

Year-to-date, Celgene has repurchased approximately $1.8 billion of its common stock and has exhausted the previous $2.5 billion stock repurchase authorization. Celgene has repurchased approximately $6.5 billion of its common stock over the last four years.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Hot Buybacks, Stock Buybacks

Related Entities

Stock Buyback

Add Your Comment